dr. o’malley on the optimal use of parp inhibitors in advanced ovarian cancer
Published 4 years ago • 95 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:11
dr. o'malley on toxicity profiles of parp inhibitors in ovarian cancer
-
1:18
dr. o'malley on the tolerability of parp inhibitors in ovarian cancer
-
1:08
dr. o'malley discusses the current role of parp inhibitors in ovarian cancer
-
1:14
dr. o'malley discusses parp combinations in ovarian cancer
-
34:13
expert views on the evolving role of parp inhibitors in the treatment of ovarian cancer
-
1:10:07
optimizing the use of parp inhibitors in ovarian cancer
-
1:29:06
the advanced ovarian cancer treatment palette: candid conversations on parp inhibitors
-
6:43
sequencing parp inhibitors in advanced ovarian cancer
-
31:30
the cancer therapy that saved my life! - sophie | stage 4 cancer | the patient story
-
8:39
#olaparib | uses, dosage, side effects & mechanism | lynparza
-
58:44
what’s new with parp inhibitors and ovarian cancer?
-
1:22
dr. gunderson on the use of parp inhibitors in all-comers with ovarian cancer
-
2:45
karen lu, md, discusses how parp inhibitors have changed the management of advanced ovarian cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
9:39
parp inhibitor selection in ovarian cancer
-
57:11
personalizing advanced ovarian cancer treatment with parp inhibitors and novel approaches
-
1:27
dr. litton on the impact of parp inhibitors in breast cancer
-
17:35
expert perspectives: the clinical potential of parp inhibitors in ovarian cancer
-
3:04
evolving role of parp inhibitors in ovarian cancer
-
0:50
dr. secord on the role of parp inhibitors in ovarian cancer
-
1:08
dr. essel on repeat use of parp inhibitors in ovarian cancer